CA918669A - Process for the preparation of benzindenes - Google Patents

Process for the preparation of benzindenes

Info

Publication number
CA918669A
CA918669A CA067476A CA67476A CA918669A CA 918669 A CA918669 A CA 918669A CA 067476 A CA067476 A CA 067476A CA 67476 A CA67476 A CA 67476A CA 918669 A CA918669 A CA 918669A
Authority
CA
Canada
Prior art keywords
benzindenes
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA067476A
Other languages
English (en)
Other versions
CA67476S (en
Inventor
W. Scott John
Saucy Gabriel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of CA918669A publication Critical patent/CA918669A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C07J15/005Retrosteroids (9 beta 10 alfa)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/16Benz[e]indenes; Hydrogenated benz[e]indenes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA067476A 1968-11-22 1969-11-14 Process for the preparation of benzindenes Expired CA918669A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77831468A 1968-11-22 1968-11-22

Publications (1)

Publication Number Publication Date
CA918669A true CA918669A (en) 1973-01-09

Family

ID=25112933

Family Applications (2)

Application Number Title Priority Date Filing Date
CA067476A Expired CA918669A (en) 1968-11-22 1969-11-14 Process for the preparation of benzindenes
CA067,962A Expired CA944770A (en) 1968-11-22 1969-11-20 Isoxazole derivatives and process therefor

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA067,962A Expired CA944770A (en) 1968-11-22 1969-11-20 Isoxazole derivatives and process therefor

Country Status (19)

Country Link
US (1) US3700661A (xx)
JP (1) JPS5022031B1 (xx)
AT (8) AT292695B (xx)
BE (4) BE742089A (xx)
BR (4) BR6914375D0 (xx)
CA (2) CA918669A (xx)
CH (10) CH529774A (xx)
DE (3) DE1958601A1 (xx)
DK (4) DK130117B (xx)
ES (5) ES373752A1 (xx)
FI (1) FI47572C (xx)
FR (4) FR2024920A1 (xx)
GB (9) GB1298211A (xx)
IE (1) IE33651B1 (xx)
IL (2) IL33369A (xx)
NL (4) NL6917499A (xx)
NO (1) NO133806C (xx)
PH (2) PH10667A (xx)
SE (5) SE361887B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984428A (en) * 1968-11-22 1976-10-05 Hoffmann-La Roche Inc. Isoxazolyl-substituted perhydrobenzindenes
US3994930A (en) * 1970-08-26 1976-11-30 Hoffmann-La Roche Inc. 6-(3-Cyanopropyl)-2-vinyl tetrahydropyran-2-ol and its tautomer
US3991084A (en) * 1970-08-26 1976-11-09 Hoffmann-La Roche Inc. Steroid total synthesis process utilizing a cyanoalkyl A-ring precursor
US3873562A (en) * 1972-06-05 1975-03-25 Hoffmann La Roche 1-(4-Isoxazolyl)-7-hydroxy-3-heptanones
US3873561A (en) * 1972-06-05 1975-03-25 Hoffmann La Roche 7-(4-Isoxazolyl)-5-oxo-heptanals
US3900491A (en) * 1972-06-05 1975-08-19 Hoffmann La Roche 1-(4-isoxazolyl)-7-hydroxy-2-hydroxyimino heptanes
US3994926A (en) * 1973-05-24 1976-11-30 Hoffmann-La Roche Inc. Aryl ketals of polycyclic oxo compounds and processes
US3855209A (en) * 1973-09-04 1974-12-17 Eastman Kodak Co Synthesis of indolininium methine dyes
US4054583A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Process for converting 2,7-dihydroxy-5-isopropylidene-9-substituted-2,6-methano-3,4,5,6-tetrahydro-2H-1-benzoxocin to trans-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo(b,d)pyran-9-one
JPH11513022A (ja) * 1995-08-02 1999-11-09 スミスクライン・ビーチャム・コーポレイション エンドセリンレセプターアンタゴニスト
US6030970A (en) * 1995-08-02 2000-02-29 Smithkline Beecham Corporation Endothelin receptor antagonists
JP2000504013A (ja) * 1996-02-01 2000-04-04 スミスクライン・ビーチャム・コーポレイション エンドセリンレセプターアンタゴニスト
US6174906B1 (en) 1999-10-01 2001-01-16 Smithkline Beecham Corporation Endothelin receptor antagonists

Also Published As

Publication number Publication date
AT292695B (de) 1971-09-10
ES373754A1 (es) 1972-04-01
NO133806C (xx) 1976-06-30
SE376422B (xx) 1975-05-26
AT299463B (de) 1972-06-26
BE742087A (xx) 1970-05-25
AT295757B (de) 1972-01-25
AT294832B (de) 1971-12-10
US3700661A (en) 1972-10-24
BR6914373D0 (pt) 1973-02-08
DK129090B (da) 1974-08-19
IE33651L (en) 1970-05-22
NL6917554A (xx) 1970-05-26
IL42366A0 (en) 1973-07-30
ES373751A1 (es) 1972-02-01
GB1298218A (en) 1972-11-29
SE361887B (xx) 1973-11-19
SE355801B (xx) 1973-05-07
DE1958600B2 (de) 1979-11-29
DE1958600A1 (de) 1970-07-09
CH561192A5 (xx) 1975-04-30
CH578547A5 (xx) 1976-08-13
DE1958608A1 (de) 1970-06-18
BR6914372D0 (pt) 1973-02-08
IE33651B1 (en) 1974-09-18
GB1298213A (en) 1972-11-29
AT294331B (de) 1971-11-25
AT308981B (de) 1973-07-25
DK127975B (da) 1974-02-11
CH529774A (de) 1972-10-31
CH567489A5 (xx) 1975-10-15
GB1298214A (en) 1972-11-29
CH537942A (de) 1973-07-31
GB1298217A (en) 1972-11-29
DK130117B (da) 1974-12-23
JPS5022031B1 (xx) 1975-07-28
ES401968A1 (es) 1976-04-16
DE1958600C3 (de) 1980-08-07
NO133806B (xx) 1976-03-22
GB1298216A (en) 1972-11-29
FI47572B (xx) 1973-10-01
SE364715B (xx) 1974-03-04
FR2024918A1 (xx) 1970-09-04
CH574890A5 (xx) 1976-04-30
GB1298211A (en) 1972-11-29
CA944770A (en) 1974-04-02
BE742089A (xx) 1970-05-25
DE1958601A1 (de) 1970-06-18
NL6917557A (xx) 1970-05-26
SE354657B (xx) 1973-03-19
PH10667A (en) 1977-08-02
CH537938A (de) 1973-07-31
ES373753A1 (es) 1973-04-16
CH567523A5 (xx) 1975-10-15
BR6914374D0 (pt) 1973-04-19
ES373752A1 (es) 1973-04-16
AT304772B (de) 1973-01-25
CH568314A5 (xx) 1975-10-31
FR2024919A1 (xx) 1970-09-04
GB1298212A (en) 1972-11-29
NL6917499A (xx) 1970-05-26
IL33369A0 (en) 1970-01-29
NL6917574A (xx) 1970-05-26
FR2030078A1 (xx) 1970-10-30
GB1298215A (en) 1972-11-29
FI47572C (fi) 1974-01-10
FR2024920A1 (xx) 1970-09-04
DK126655B (da) 1973-08-06
BR6914375D0 (pt) 1973-04-19
DK130117C (xx) 1975-06-09
BE742088A (xx) 1970-05-25
BE742090A (xx) 1970-05-25
CH567490A5 (xx) 1975-10-15
AT292694B (de) 1971-09-10
GB1298219A (en) 1972-11-29
PH11342A (en) 1977-11-02
IL33369A (en) 1973-10-25

Similar Documents

Publication Publication Date Title
CA918669A (en) Process for the preparation of benzindenes
CA928298A (en) Process for the preparation of 3-alkylflavanones
CA781514A (en) Process for the preparation of diorganohalophosphines
CA802926A (en) Process for the preparation of phenyltrichloroacetoimidochlorides
AU447701B2 (en) Process for the preparation of n-tritylimidazoles
CA779320A (en) Process for the preparation of hexa-organo-distannoxanes
CA779884A (en) Process for the preparation of diphenylalkylamines
CA785752A (en) Process for the preparation of 2-hydroxy-methylene-19-nor-steroids
AU294987B2 (en) Process for the preparation of 19-hydroxy-steroids
CA791124A (en) Process for the preparation of 21-halonorethisterones
CA796322A (en) Process for the preparation of pyridoxines
CA783052A (en) Process for the preparation of substituted phenylisothiazolylpenicillins
AU4390368A (en) Process for the preparation of n-tritylimidazoles
AU3463968A (en) Process for the preparation of 19-hydroxy-steroids
CA781932A (en) Process for the preparation of reserpine-like compounds
CA792744A (en) Process for the preparation of cyclopentanopolyhydro-phenanthrene derivatives
CA786377A (en) Process for the preparation of alpha substituted alkanedinitriles
CA777183A (en) Method for the preparation of arylisothiocyanates
CA776702A (en) Method for the preparation of arylisothiocyanates
CA796758A (en) Process for the preparation of new p-alkyl-benzyl-tropinium derivatives
CA799490A (en) Process for the manufacture of aminoisoxazoles
CA786240A (en) Process for the manufacture of magnesium-ammonium phosphate-hexahydrate
CA793308A (en) Process for the manufacture of 3-amino-cholestanes
CA795311A (en) Process for the manufacture of b-nor- or b-nor-19-nor-androstanes
CA793313A (en) Process for the manufacture of 1-glycosyl-5-azacytosines